None
SEDAR Interim Financial Statements
HYTN · Price
[
{
"companyName": "HYTN Innovations Inc.",
"reportingPeriodEnd": "2025-12-31",
"reportStatus": "Unaudited",
"auditorName": null,
"auditorKeyMatters": [],
"balanceSheet": {
"cash": 56947,
"restrictedCash": 587,
"accountsReceivable": 482845,
"inventory": 601945,
"prepaidExpenses": 425,
"totalCurrentAssets": 1142749,
"propertyPlantAndEquipment": 1570765,
"intangibleAssets": 40439,
"deposits": 103972,
"totalNonCurrentAssets": 1715176,
"totalAssets": 2857925,
"accountsPayableAndAccruedLiabilities": 2207952,
"loansPayable": 228049,
"leaseLiabilityCurrent": 142628,
"contingentConsiderationPayable": 45000,
"totalCurrentLiabilities": 2623629,
"leaseLiabilityNonCurrent": 733999,
"decommissioningProvision": 737000,
"totalNonCurrentLiabilities": 1470999,
"totalLiabilities": 4094628,
"shareCapital": 19497502,
"warrantReserve": 2776,
"stockBasedPaymentReserve": 1801091,
"equityContributionToSubsidiary": -54655,
"deficit": -22483417,
"totalShareholdersEquityDeficit": -1236703,
"cashPerShare": 0.0006,
"workingCapitalPerShare": -0.0158
},
"incomeStatement": {
"revenues": 1460781,
"costOfSales": 784480,
"grossProfit": 676301,
"advertisingAndMarketing": 1422,
"consultingExpense": 45000,
"depreciation": 26131,
"amortization": 2889,
"officeAndMiscellaneous": 65548,
"professionalFees": 63296,
"salariesAndPayroll": 186257,
"sellingCosts": 338634,
"stockBasedCompensation": 171781,
"transferAgentAndFilingFees": 8778,
"travel": 6077,
"operatingExpenses": 915813,
"totalOperatingLoss": -239512,
"changeInDecommissioningProvision": -13000,
"interestAccretionExpense": -33207,
"gainOnContingentConsiderationPayableRevaluation": -2700,
"netLossAndComprehensiveLoss": -288419,
"lossPerShareBasicAndDiluted": 0,
"weightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted": 93708107
},
"cashFlowStatement": {
"netLossForTheYear": -288419,
"itemsNotAffectingCash": {
"depreciation": 52381,
"amortization": 2889,
"stockBasedCompensation": 171781,
"changeInDecommissioningProvision": 13000,
"interestAccretionExpense": 37101,
"gainLossOnContingentConsiderationPayableRevaluation": 2700
},
"netChangesInNonCashWorkingCapitalItems": {
"accountsReceivable": -283973,
"prepaidExpenses": 6877,
"inventory": 705658,
"accountsPayableAndAccruedLiabilitiesAndProvisionForReturns": -468900,
"accruedInterest": 12797
},
"cashUsedInOperatingActivities": -36108,
"purchaseOfPropertyPlantAndEquipment": -9332,
"cashUsedInInvestingActivities": -9332,
"warrantExerciseProceedsReceived": 0,
"repaymentOfLeaseLiability": -42128,
"repaymentOfIndebtedness": -200000,
"cashUsedInProvidedByFinancingActivities": -242128,
"netChangeInCash": -287569,
"cashBeginningOfYear": 344515,
"cashEndOfYear": 56947
},
"investmentsAndOtherAssets": [
{
"type": "Intangible Asset",
"description": "Exclusive license to Lux Sit Systems Inc. technologies for cultivation of psilocybin-containing mushrooms (Licensed IP)",
"ownershipPercentage": null,
"value": 40439,
"notes": "Acquired via Prism Scientific Labs Inc. acquisition. License term expires June 4, 2029. Carrying value net of amortization."
},
{
"type": "Deposit",
"description": "Various deposits",
"ownershipPercentage": null,
"value": 103972,
"notes": "Non-current asset"
}
],
"shareStructure": {
"authorizedShares": "unlimited",
"issuedShares": 93708107,
"classesOfShares": ["Class A common voting shares"],
"warrants": [
{
"number": 8700670,
"exercisePrice": 0.25,
"expiryDate": "2026-03-25"
}
],
"options": [
{
"number": 825000,
"exercisePrice": 0.35,
"expiryDate": "2026-02-17"
},
{
"number": 150000,
"exercisePrice": 0.35,
"expiryDate": "2026-02-21"
},
{
"number": 825000,
"exercisePrice": 0.12,
"expiryDate": "2027-11-06"
}
],
"rightsConvertibleInstruments": "10,000,000 Performance Warrants with revenue-based vesting milestones ($5M and $8M over 12 consecutive months). Exercise price $0.05, 5-year term. No fair value recognized due to low probability of milestones being met."
},
"managementCompensation": {
"currency": "CAD",
"periods": {
"2025": {
"equityIncentivesGranted": 1350000,
"equityIncentiveGrantAmount": 149736,
"equityIncentiveVested": 165500,
"fees": 165500
},
"2024": {
"equityIncentivesGranted": 0,
"equityIncentiveGrantAmount": 41228,
"equityIncentiveVested": 41228,
"fees": 165500
}
},
"namedIndividuals": [
{
"name": "CEO and Director",
"title": "CEO and Director",
"period": "2025",
"components": {
"salary": 50000,
"bonus": null,
"total": 50000
}
},
{
"name": "COO and Director",
"title": "COO and Director",
"period": "2025",
"components": {
"salary": 62500,
"bonus": null,
"total": 62500
}
},
{
"name": "CFO",
"title": "CFO",
"period": "2025",
"components": {
"salary": null,
"bonus": null,
"total": 22500
}
},
{
"name": "A Director of the Company",
"title": "Director",
"period": "2025",
"components": {
"salary": null,
"bonus": null,
"total": 7500
}
},
{
"name": "A company controlled by a significant shareholder",
"title": "Consultant",
"period": "2025",
"components": {
"salary": null,
"bonus": null,
"total": 23000
}
}
],
"otherRelatedPartyTransactions": [
{
"counterparty": "Lender controlled by a significant shareholder",
"description": "Promissory note and loan agreement, unsecured, 15% interest, due on demand",
"amount": 228049,
"period": "2025"
},
{
"counterparty": "Key management personnel and a company controlled by a significant shareholder",
"description": "Accounts payable and accrued liabilities for fees and expenses incurred on behalf of the Company",
"amount": 904910,
"period": "2025"
}
]
},
"subsequentEvents": []
}
]
More from HYTN Innovations Inc
May 07, 2026 · 17:00